| NCT ID | NCT05454969 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Literacy |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-09-01 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to improve health outcomes of individuals and populations, enhance the patient experience, reduce the per capita cost of care, and ensure the well-being of our healthcare providers (quadruple aim). These goals are increasingly difficult to achieve, given the challenges of changes to workflow, staffing shortages, and increased costs brought on by the COVID-19 pandemic. Further, the pandemic brought to light the critical need to transform healthcare access for our racially and culturally minoritized and low-income families that have long been victims of health disparities, specifically with poorer health outcomes.
Eligibility Criteria
Inclusion Criteria: * All guardians of patients and the providers (surgeons, doctors, nurses, etc) that serve these patients. Exclusion Criteria: * None.
Contact & Investigator
Jill Landsbaugh Kaar, PhD
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT05454969 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Literacy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05454969 currently recruiting?
Yes, NCT05454969 is actively recruiting participants. Contact the research team at jill.kaar@cuanschutz.edu for enrollment information.
Where is the NCT05454969 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT05454969 clinical trial?
NCT05454969 is sponsored by University of Colorado, Denver. The principal investigator is Jill Landsbaugh Kaar, PhD at University of Colorado, Denver. The trial plans to enroll 100 participants.